Khaled Omar Mohamed

Prof. Dr. Khaled Omar Mohamed

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2020 in Archiv der Pharmazie
Verified
Journal Article
Closed access
PDF file
MSMohamed A. Shaaban
Mohamed A. Shaaban
AKAliaa M. Kamal
Aliaa M. Kamal
SFSamar I. Faggal
Samar I. Faggal
NFNahla A. Farag
Nahla A. Farag
NANora M. Aborehab
Nora M. Aborehab
KMKhaled Omar Mohamed
Khaled Omar Mohamed

7 February 2020 in Archiv der Pharmazie
Verified
Journal Article
Closed access
PDF file
MSMohamed A. Shabaan
Mohamed A. Shabaan
AKAliaa M. Kamal
Aliaa M. Kamal
SFSamar I. Faggal
Samar I. Faggal
AEAyman E. Elsahar
Ayman E. Elsahar
KMKhaled Omar Mohamed
Khaled Omar Mohamed

1 September 2022 in Symmetry
Verified
Journal Article
Open access
PDF file
TATarfah Al-Warhi
Tarfah Al-Warhi
MAMatokah Abualnaja
Matokah Abualnaja
OAOla Abuali
Ola Abuali
NANajiah Alyamani
Najiah Alyamani
FEFahmy Elsaid
Fahmy Elsaid
IZIslam Zaki
Islam Zaki
Z-configurated isomers are kinetically preferred molecules. Compounds with Z-configuration are contained in many natural products, biologically active compounds and as synthons for organic synthesis. Two series of new thiazole-based analogs were synthesized from appropriate starting materials hydrazinecarbothioamide derivatives (Z)-2a,b to be evaluated for their inhibitory activity towards VEGFR-2. The prepared thiazole compounds 3a-5b were screened for their cytotoxic potency against the MDA-MB-231 breast cancer cell line and their percentage inhibition against VEGFR-2. Compound 4d exhibited good VEGFR-2 inhibitory activity. A DNA flow cytometry analysis was conducted, and compound 4d demonstrated cell cycle arrest at the G1 and G2/M phases of the cell cycle profile and an apoptosis-inducing effect by increasing the percentage of pre-G1 phase. Compound 4d was further evaluated for its apoptosis-inducing effect by studying the effect on mitochondrial membrane potential (MMP) and p53 activation. It was found to boost the level of p53 and reduce the level of MMP compared with the untreated control cells.

1 August 2020 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
MSMohamed A. Shaaban
Mohamed A. Shaaban
YEYaseen Elshaier
Yaseen Elshaier
AHAli H. Hammad
Ali H. Hammad
NFNahla A. Farag
Nahla A. Farag
HHHaredy Hassan Haredy
Haredy Hassan Haredy
KMKhaled Omar Mohamed
Khaled Omar Mohamed

2 October 2021 in Molecules
Verified
Journal Article
Open access
PDF file
AKAhdab Khayyat
Ahdab Khayyat
KMKhaled Omar Mohamed
Khaled Omar Mohamed
AMAzizah Malebari
Azizah Malebari
AEAfaf El-MalahMalah
Afaf El-MalahMalah
A new series of benzotriazole moiety bearing substituted imidazol-2-thiones at N1 has been designed, synthesized and evaluated for in vitro anticancer activity against the different cancer cell lines MCF-7(breast cancer), HL-60 (Human promyelocytic leukemia), and HCT-116 (colon cancer). Most of the benzotriazole analogues exhibited promising antiproliferative activity against tested cancer cell lines. Among all the synthesized compounds, BI9 showed potent activity against the cancer cell lines such as MCF-7, HL-60 and HCT-116 with IC50 3.57, 0.40 and 2.63 µM, respectively. Compound BI9 was taken up for elaborate biological studies and the HL-60 cells in the cell cycle were arrested in G2/M phase. Compound BI9 showed remarkable inhibition of tubulin polymerization with the colchicine binding site of tubulin. In addition, compound BI9 promoted apoptosis by regulating the expression of pro-apoptotic protein BAX and anti-apoptotic proteins Bcl-2. These results provide guidance for further rational development of potent tubulin polymerization inhibitors for the treatment of cancer.

31 October 2023 in RSC Advances
Verified
Journal Article
Open access
PDF file
NRNada Reda
Nada Reda
AEAhmed Elshewy
Ahmed Elshewy
HEHesham I. El-Askary
Hesham I. El-Askary
KMKhaled Omar Mohamed
Khaled Omar Mohamed
AHAmira A. Atef Ahmed Helwa
Amira A. Atef Ahmed Helwa
A series of pyrimidine-5-carbonitriles was designed and synthesized as potential anti-cancer agents with dual EGFR WT /COX-2 inhibition. Compounds 4e and 4f disclosed the highest activity on all NCI60 cell lines.